目的：观察国产“天普络欣”（尿激酶）在急性心肌梗塞（AMI）静脉溶栓治疗中的临床疗效和不良反应，对其安全性和疗效作出评价。方法：根据天普络欣溶栓治疗急性心肌梗塞协作方案，共收集48例病例。治疗中辅以肝素钙和肠溶阿司匹林。所有入选病例均符合入选和不入选标准。给予尿 Objective: To observe the clinical efficacy and adverse reactions of domestic “Tianluoluoxin” (urokinase) in intravenous thrombolytic therapy of acute myocardial infarction (AMI) and to evaluate its safety and efficacy. Methods: According to Tianpuluoxin thrombolytic therapy of acute myocardial infarction cooperation program, a total of 48 cases were collected. Treatment is supplemented with heparin calcium and enteric-coated aspirin. All selected cases met the inclusion and non-inclusion criteria. Give urine